Posts Archive

Important update from the ThrombUS+ Horizon Europe project: ethics approved and first patient enrolled! This advancement is a critical step in the creation of a wearable device that detects deep vein thrombosis (DVT).

News and accomplishments from the first year of the ThrombUS+ Horizon Europe project. ThrombUS+ is a medical device that incorporates wearable ultrasound hardware, impedance plethysmography, and light reflection rheography for immediate clot detection and prevention of Deep Vein Thrombosis (DVT).

Telemed is a pioneer in the field of medical imaging and ultrasound technology. Read about their involvement in the ThrombUS+ Horizon Europe project to develop a novel wearable diagnostic device for early detection of Deep Vein Thrombosis.

Fraunhofer IPMS is a pivotal member of the ThrombUS+ project. Read more about their involvement in developing a novel wearable diagnostic device for early detection of Deep Vein Thrombosis.

The ThrombUS+ Horizon Europe project was presented at the 9th European Medical and Biological Engineering Conference (EMBEC) in June 2024 by project manager Stylianos Didaskalou of Athena Research Center.

Learn more about Vermon, designer and manufacturer of ultrasound transducers and partner in the ThrombUS+ Horizon EU project, working to create a wearable device to diagnose deep vein thrombosis (DVT).

The ThrombUS+ Horizon Europe project, tasked with creating a novel wearable diagnostic device to detect Deep Vein Thrombosis, met for the second time this week in Kaunas, Lithuania.

Kaunas University of Technology (KTU) is a top technical university in the Baltic region with 9,000+ students and 2,500 staff. The University focuses on sustainable partnerships between science, business and industry, developing and implementing new ideas, innovations and inventions.